RAPID MICRO BIOSYSTEMS INC-A
RPID · NASDAQ
Updated at 2026-10-15 08:28:24
- Today's High
- $0.87
- Today’s Low
- $0.80
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.84
- Previous Close
- $0.81
- Volume
- 145.1K
- Market Cap
- $40.99M
- P/E Ratio
- --
- EPS
- $-1.11
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 25 HARTWELL AVENUE, LEXINGTON, MA, UNITED STATES, 02421
- Country
- US
- Listing Date
- 2021-07-15
- Fiscal Year End
- December
- Shares Outstanding
- 49.42M
- CIK
- 0001380106
- Website
- www.rapidmicrobio.com
Rapid Micro Biosystems Inc (RPID) is an innovative biotechnology firm at the forefront of revolutionizing microbiological quality control for the pharmaceutical and biotechnology industries. Utilizing advanced automated microbial detection technologies, RPID significantly improves the accuracy and efficiency of microbial testing, addressing the stringent regulatory requirements within these sectors. As the demand for rapid quality assurance solutions continues to grow, Rapid Micro is well-positioned to spearhead advancements in testing methodologies, ensuring product safety and integrity in highly regulated environments.
Financial Metrics
Revenue
2026-06-30
$8.05M
2026-03-31
$8M
2025-12-31
$11.28M
2025-09-30
$7.83M
Operating Expenses
2026-06-30
$13.53M
2026-03-31
$14.22M
2025-12-31
$11.88M
2025-09-30
$13.64M
Net Income
2026-06-30
-$12.92M
2026-03-31
-$14.27M
2025-12-31
-$12.49M
2025-09-30
-$11.5M
Net Profit Margin
2026-06-30
-160.45%
2026-03-31
-178.39%
2025-12-31
-110.77%
2025-09-30
-146.78%
Earnings Per Share
2026-06-30
$-0.27
2026-03-31
$-0.31
2025-12-31
$-0.28
2025-09-30
$-0.26
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$11.55M
2026-03-31
-$12.92M
2025-12-31
-$10.88M
2025-09-30
-$10.27M
Effective Tax Rate
2026-06-30
-0.34%
2026-03-31
-0.05%
2025-12-31
-0.11%
2025-09-30
-0.06%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $8.05M | $8M | $11.28M | $7.83M |
| Operating Expenses | $13.53M | $14.22M | $11.88M | $13.64M |
| Net Income | -$12.92M | -$14.27M | -$12.49M | -$11.5M |
| Net Profit Margin | -160.45% | -178.39% | -110.77% | -146.78% |
| Earnings Per Share | $-0.27 | $-0.31 | $-0.28 | $-0.26 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$11.55M | -$12.92M | -$10.88M | -$10.27M |
| Effective Tax Rate | -0.34% | -0.05% | -0.11% | -0.06% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.